Scinai Immunotherapeutics (SCNI) Other Non Operating Income (2022 - 2026)

Scinai Immunotherapeutics (SCNI) has 4 years of Other Non Operating Income data on file, last reported at $6.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income changed N/A year-over-year to $6.2 million; the trailing twelve-month figure through Mar 2026 stood at $19.7 million (changed N/A YoY), and the FY2024 full-year result was $14.8 million, up 163888.89% from the prior year.
• Other Non Operating Income climbed to $6.2 million in Q1 2026, from $1.4 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $12.9 million in Q3 2024 to a low of -$5.2 million in Q3 2023.
• A 4-year average of $1.4 million and a median of $280000.0 in 2023 frame the typical range for Other Non Operating Income.
• Peak annual rise in Other Non Operating Income reached 1261.54% in 2023, while the deepest fall reached 1361.26% in 2023.
• Tracing SCNI's Other Non Operating Income over 4 years: stood at $4.6 million in 2022, then sank by 179.83% to -$3.7 million in 2023, then jumped by 137.39% to $1.4 million in 2024, then surged by 344.48% to $6.2 million in 2026.
• Business Quant data shows SCNI's Other Non Operating Income at $6.2 million in Q1 2026, $1.4 million in Q4 2024, and $12.9 million in Q3 2024.